ursolic acid has been researched along with Leishmaniasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Croft, SL; Loiseau, PM; Pomel, S | 1 |
| Bera, T; Das, S; De, AK; Ghosh, S | 1 |
1 review(s) available for ursolic acid and Leishmaniasis
| Article | Year |
|---|---|
Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Betulinic Acid; Biocompatible Materials; Chitosan; Curcumin; Drug Carriers; Drug Compounding; Humans; Hydrogen-Ion Concentration; Leishmaniasis; Leishmaniasis Vaccines; Macrophages; Nanoparticles; Paromomycin; Pentacyclic Triterpenes; Polymers; Rifampin; Selenium; Thiomalates; Titanium; Triterpenes; Ursolic Acid | 2020 |
1 other study(ies) available for ursolic acid and Leishmaniasis
| Article | Year |
|---|---|
Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis.
Topics: Administration, Oral; Animals; Chitosan; Drug Carriers; Drug Design; Drug Liberation; Female; Leishmaniasis; Lipids; Macrophages; Male; Mice; Mice, Inbred BALB C; Nanostructures; Oligosaccharides; Triterpenes; Ursolic Acid | 2017 |